£3,321,647,654

RAISED FOR OUR CLIENTS SINCE 2013

We are a leading investment bank and stockbroker dedicated to serving the small and mid cap sector in the UK

N+1 Singer shares its H1 2018 Review

In our H1 review, we discuss the UK economic and equity market environment and notable transactions completed in the first half of 2018.

READ REVIEW

Thomson Reuters Analyst Awards 2018

We are delighted to announce that the N+1 Singer Life Sciences and Healthcare Team has been ranked ‘Top Earnings Estimator’ in Biotechnology for the Europe region for 2018. The awards are globally recognised as the gold

Hipgnosis Songs Fund Ltd Publicly Lists on the Specialist Fund Segment

Today marks the first day of dealings for Hipgnosis Songs Fund Ltd, as they list on the Specialist Fund Segment on the Main Market on the London Stock Exchange. Founded by Merck Mercuriadis, former manager

[Video] N+1 Singer’s Emerging Companies Lunch

Last Thursday we held our second ‘Emerging Companies Lunch’ hosted at The NED, in the City of London. Our private company lunches pair up fast-growing private companies with fund managers focused on small cap opportunities. For

N+1 Singer Best Ideas 2018 – H1 Review, 9% Outperformance

In our January blog we introduced our 16 “Best Ideas” for 2018 and alluded (perhaps tempting fate) to our strong track record for this portfolio over many years. It is with pride and relief then that […]